Navigation Links
Metformin Won't Aid Breast Cancer Survival in Diabetics
Date:5/14/2013

TUESDAY, May 14 (HealthDay News) -- Despite prior research suggesting that the widely used diabetes drug metformin might help cancer patients, a new study finds it does not boost survival for older breast cancer patients with diabetes.

Previous research has found that metformin was associated with an up to 30 percent reduction in new cancers in breast cancer patients without diabetes, noted study author Dr. Iliana Lega, a research fellow at Women's College Hospital in Toronto. Prior research has also tied use of the drug to slowed tumor growth.

"Metformin is a drug commonly used by diabetic patients to control the amount of glucose [sugar] in their blood," Lega explained in a hospital news release. "Although existing scientific literature suggests that the drug may prevent new cancers and death from breast cancer, our study found the drug did not significantly impact survival rates in our patients."

The study included more than 2,300 women, aged 66 and older, with diabetes who took metformin and were diagnosed with breast cancer between 1997 and 2008. The women were followed from the time of their diagnosis until their death or until early 2010.

Metformin use was not associated with any significant drop in breast cancer deaths, according to the study published online recently in the journal Diabetes Care.

"What makes our study so unique is that while the effects of metformin have been well documented, previous research has not examined the cumulative effects of the drug on patients, particularly breast cancer patients with diabetes," Lega said. "This is important given that diabetic patients may switch drugs over the course of their treatment."

She and her colleagues said further research is necessary in younger patients who have both breast cancer and diabetes.

"Understanding the effects of metformin on breast cancer patients is critical in helping address the gap in cancer outcomes in patients with and without diabetes," Lega explained. "The findings will help physicians inform treatment plans for patients with diabetes."

More information

The U.S. National Cancer Institute has more about breast cancer.

-- Robert Preidt

SOURCE: Women's College Hospital, news release, May 9, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Added benefit of saxagliptin/metformin combination is not proven
2. Metformin improves blood glucose levels and BMI in very obese children
3. Study: Metformin offers cardio benefits over sulfonylureas in diabetes
4. Metformin may lower cancer risk in people with Type 2 diabetes
5. Metformin Outperforms Common Class of Diabetes Drugs in Study
6. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
7. Cognitive training improves executive function in breast cancer survivors
8. A Little Formula Might Help Breast-Feeding for Some Babies
9. Socializing May Ease Pain of Breast Cancer
10. Fun and friends help ease the pain of breast cancer
11. Just How Might Exercise Lower Breast Cancer Risk?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Metformin Won't Aid Breast Cancer Survival in Diabetics
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology: